Cargando…
Radionuclide-based molecular imaging allows CAR-T cellular visualization and therapeutic monitoring
Chimeric antigen receptor T cell (CAR-T) therapy is a new and effective form of adoptive cell therapy that is rapidly entering the mainstream for the treatment of CD19-positive hematological cancers because of its impressive effect and durable responses. Huge challenges remain in achieving similar s...
Autores principales: | Shao, Fuqiang, Long, Yu, Ji, Hao, Jiang, Dawei, Lei, Ping, Lan, Xiaoli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171102/ https://www.ncbi.nlm.nih.gov/pubmed/34093854 http://dx.doi.org/10.7150/thno.56989 |
Ejemplares similares
-
Adriamycin cardiotoxicity monitoring by radionuclide scan.
por: Robinson, B. A., et al.
Publicado: (1983) -
Accumulation of radionuclides by plants as a monitor system.
por: Koranda, J J, et al.
Publicado: (1978) -
Radionuclide-Based Imaging of Breast Cancer: State of the Art
por: Li, Huiling, et al.
Publicado: (2021) -
Advances in Radionuclides and Radiolabelled Peptides for Cancer Therapeutics
por: Chakraborty, Kushal, et al.
Publicado: (2023) -
Individual monitoring for intakes of radionuclides by workers: design and interpretation
por: Commission Internationale de Protection contre les Radiations
Publicado: (1988)